Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
A phase I open label study of fostamatinib, a SYK inhibitor, in patients with lower-risk myelodysplastic syndrome and chronic myelomonocytic leukemia.
Journal: Leukemia & lymphoma
Published: March 30, 2026
Poly(ADP-ribose) polymerase inhibitor maintenance therapy in ovarian cancer: a single-center retrospective study.
Journal: Frontiers in oncology
Published: December 19, 2025
Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in Ovarian Cancer Cells and a Transgenic Mouse Model of Ovarian Cancer.
Journal: International journal of molecular sciences
Published: June 26, 2023
Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian Cancer.
Journal: Frontiers in oncology
Published: October 04, 2021
Docosahexaenoic acid (DHA), an omega-3 fatty acid, inhibits tumor growth and metastatic potential of ovarian cancer.
Journal: American journal of cancer research
Published: September 22, 2020
Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 21, 2020
Current First-line Therapy for Ovarian Cancer: A Comprehensive Review.
Journal: Obstetrical & gynecological survey
Published: November 24, 2018
ONC201 demonstrates anti-tumorigenic and anti-metastatic activity in uterine serous carcinoma in vitro.
Journal: American journal of cancer research
Published: June 25, 2018
Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse.
Journal: Leukemia
Published: September 19, 2017
Influence of IDH on FLT3-ITD status in newly diagnosed AML.
Journal: Leukemia
Published: July 29, 2017
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials.
Journal: Leukemia
Published: March 25, 2017
Nonoperative management of atypical endometrial hyperplasia and grade 1 endometrial cancer with the levonorgestrel intrauterine device in medically ill post-menopausal women.
Journal: Gynecologic oncology
Published: January 23, 2017
Last Updated: 09/26/2026